AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+26.41%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$8.88B
AUM Growth
+$2.09B
(+31%)
Cap. Flow
+$626M
Cap. Flow
% of AUM
7.05%
Top 10 Holdings %
Top 10 Hldgs %
40.05%
Holding
908
New
100
Increased
273
Reduced
455
Closed
75
Top Buys
| 1 |
Energy Transfer Partners
ET
|
$77.7M |
| 2 |
Enterprise Products Partners
EPD
|
$67.6M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$47M |
| 4 |
MPLX
MPLX
|
$24.1M |
| 5 |
Plains All American Pipeline
PAA
|
$23.4M |
Top Sells
| 1 |
WRK
WestRock Company
WRK
|
$24.6M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
$24.6M |
| 3 |
Eastman Chemical
EMN
|
$23M |
| 4 |
Broadcom
AVGO
|
$22.5M |
| 5 |
Duke Energy
DUK
|
$20.8M |
Sector Composition
| 1 | Energy | 48.15% |
| 2 | Financials | 11.06% |
| 3 | Technology | 7.05% |
| 4 | Healthcare | 5.49% |
| 5 | Industrials | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
376
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.13M | 0.01% |
7,255
-690
| -9% | -$108K |
|
|
VXRT
377
DELISTED
Vaxart
VXRT
| $1.13M | 0.01% |
+197,384
| New | +$1.13M |
|
|
ISEE
378
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.12M | 0.01% |
161,774
+47,635
| +42% | +$329K |
|
|
SBLX
379
StableX Technologies, Inc. Common Stock
SBLX
$3.15M
| $1.09M | 0.01% |
+1,400
| New | +$1.09M |
|
380
Monolithic Power Systems
MPWR
$41.5B
| $1.09M | 0.01% |
2,970
-288
| -9% | -$106K |
|
381
Dollar General
DG
$24.1B
| $1.08M | 0.01% |
5,157
-247
| -5% | -$51.9K |
|
382
Zebra Technologies
ZBRA
$16B
| $1.08M | 0.01% |
2,800
-236
| -8% | -$90.7K |
|
383
Alphabet (Google) Class A
GOOGL
$2.84T
| $1.06M | 0.01% |
12,140
-10,820
| -47% | -$948K |
|
384
AnaptysBio
ANAB
$613M
| $1.06M | 0.01% |
49,352
+14,538
| +42% | +$313K |
|
385
Harmony Gold Mining
HMY
$8.78B
| $1.03M | 0.01% |
219,118
-686,655
| -76% | -$3.21M |
|
386
Brookfield Infrastructure
BIPC
$4.75B
| $1.02M | 0.01% |
21,132
| – | – |
|
387
AngloGold Ashanti
AU
$30.2B
| $1.01M | 0.01% |
44,739
-215,335
| -83% | -$4.87M |
|
388
CubeSmart
CUBE
$9.52B
| $1.01M | 0.01% |
29,897
+14,007
| +88% | +$471K |
|
389
Elevance Health
ELV
$70.6B
| $1M | 0.01% |
3,122
-711
| -19% | -$228K |
|
390
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $1M | 0.01% |
+56,627
| New | +$1M |
|
391
Alaunos Therapeutics
TCRT
$4.27M
| $975K | 0.01% |
+2,581
| New | +$975K |
|
392
Xenon Pharmaceuticals
XENE
$3.02B
| $973K | 0.01% |
63,254
+18,630
| +42% | +$287K |
|
393
Gold Fields
GFI
$30.8B
| $970K | 0.01% |
104,660
-328,488
| -76% | -$3.04M |
|
394
Fulton Financial
FULT
$3.53B
| $963K | 0.01% |
75,683
-3,567
| -5% | -$45.4K |
|
395
Entegris
ENTG
$12.4B
| $938K | 0.01% |
9,761
-726
| -7% | -$69.8K |
|
|
TECX
396
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $918K | 0.01% |
5,489
+1,617
| +42% | +$270K |
|
|
SYRS
397
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $897K | 0.01% |
8,271
+2,435
| +42% | +$264K |
|
398
Geron
GERN
$893M
| $892K | 0.01% |
+561,172
| New | +$892K |
|
399
Catalyst Pharmaceutical
CPRX
$2.48B
| $885K | 0.01% |
265,002
+52,699
| +25% | +$176K |
|
400
89bio
ETNB
$1.32B
| $876K | 0.01% |
+35,931
| New | +$876K |
|